Organigram Global Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.700
-0.020 (-1.16%)
Oct 22, 2025, 10:31 AM EDT - Market open
Organigram Global Revenue
Organigram Global had revenue of 70.79M CAD in the quarter ending June 30, 2025, with 72.41% growth. This brings the company's revenue in the last twelve months to 223.82M, up 50.01% year-over-year. In the fiscal year ending September 30, 2024, Organigram Global had annual revenue of 159.84M with 7.13% growth.
Revenue (ttm)
223.82M CAD
Revenue Growth
+50.01%
P/S Ratio
1.42
Revenue / Employee
249,243 CAD
Employees
898
Market Cap
232.90M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 159.84M | 10.64M | 7.13% |
Sep 30, 2023 | 149.21M | 3.40M | 2.33% |
Aug 31, 2022 | 145.81M | 66.65M | 84.19% |
Aug 31, 2021 | 79.16M | -7.63M | -8.79% |
Aug 31, 2020 | 86.80M | 6.38M | 7.94% |
Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Aug 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
OGI News
- 1 day ago - Organigram Global Announces Update to CEO Succession Plan - Business Wire
- 6 days ago - 3 Canadian Cannabis Stocks to Watch as U.S. Legalization Gains Steam in 2025 - MarijuanaStocks
- 13 days ago - Organigram Global Launches happly, a New U.S. Hemp-Derived THC Brand Offering Targeted Formulations for Three Mood States; Socialize, Relax, and Sleep - Business Wire
- 22 days ago - OrganiGram (OGI) Joins Cannabis Stock Rally After Trump Signals Policy Shift - Benzinga
- 7 weeks ago - Organigram Global Releases Landmark Report: Legal Cannabis Added $16B to Canada's GDP in 2024 - Business Wire
- 2 months ago - Organigram: The Capital Efficient Market Leader Trading At A Discount - Seeking Alpha
- 2 months ago - Organigram Global Inc. (OGI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Organigram Posts Wider Loss, Eyes Profitability In Near Term - Benzinga